規格 | 目錄價格 | 上海 | 安徽 | 武漢 | 成都 | 北方 | 深圳 | 會員價格 | 數量 |
---|---|---|---|---|---|---|---|---|---|
100mg | ¥ ????? | > 10 | > 10 | -- | 1 | 3 | 3 | ¥ ????? | - + |
250mg | ¥ ō???? | > 10 | > 10 | -- | 4 | 5 | 1 | ¥ ō???? | - + |
1g | ¥ ?????? | 8 | > 10 | -- | 5 | 6 | 4 | ¥ ?????? | - + |
5g | ¥ ???ō??? | 1 | 7 | -- | 2 | 3 | 2 | ¥ ???ō??? | - + |
10g | ¥ ??????? | -- | 3 | -- | -- | -- | -- | ¥ ??????? | - + |
25g | ¥ ??????? | -- | 1 | -- | 1 | -- | 1 | ¥ ??????? | - + |
100g | 請詢價 | -- | -- | -- | -- | -- | -- | -- | - + |
500g | 請詢價 | -- | -- | -- | -- | -- | -- | -- | - + |
1000g | 請詢價 | -- | -- | -- | -- | -- | -- | -- | - + |
產品編號
1199258
CAS 號
76410-58-7
中文名稱
(S)-2-氨基-3-(4-硼苯基)丙酸
MDL 號
MFCD01075172
分子量
209.01
存儲條件
2-8°C
網頁展示純度為入庫指導純度值,各批次間存在一定差異,實際純度以收貨為準
熔點
285-293 °C
沸點
449.3±55.0 °C at 760 mmHg
閃點
旋光
描述
TPSA
103.78
LogP
-1.6792
H_Acceptors
4
H_Donors
4
Rotatable_Bonds
4
[1]. A Dagrosa, et al. Studies for the application of boron neutron capture therapy to the treatment of differentiated thyroid cancer. Appl Radiat Isot. 2011 Dec;69(12):1752-5.
[2]. Andrea Wittig, et al. EORTC trial 11001: distribution of two 10B-compounds in patients with squamous cell carcinoma of head and neck, a translational research/phase 1 trial. J Cell Mol Med. 2009 Aug;13(8B):1653-1665.
[3]. Feng-Yi Yang, et al. Pharmacokinetic analysis and uptake of 18F-FBPA-Fr after ultrasound-induced blood-brain barrier disruption for potential enhancement of boron delivery for neutron capture therapy. J Nucl Med. 2014 Apr;55(4):616-21.
[4]. G S Cruickshank, et al. A cancer research UK pharmacokinetic study of BPA-mannitol in patients with high grade glioma to optimise uptake parameters for clinical trials of BNCT. Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S31-3.
[5]. Peng Wang, et al. Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax. BMC Cancer. 2010 Dec 2:10:661.
警示圖
警示詞
Warning
危險申明
H315-H319-H335
警告申明
P261-P264-P271-P280-P302+P352-P304+P340-P362+P364-P405-P501
GHS 編碼
GHS07
展開更多
現貨供應
專業護航
售后無憂
品質保障
無需湊單